Study showing effectiveness of Nalbuphine as an adjuvant to Bupivacaine in supraclavicular brachial plexus block.
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/12/038423
- Lead Sponsor
- GOVERNMENT MEDICAL COLLEGEBHAVNAGAR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)American Society of Anesthesiologists (ASA) physical status I to II of either gender
2) Age: 18â??58 years
3) Patients scheduled for elective forearm and hand surgeries in orthopaedic operation theaters.
Exclusion Criteria
1) Patients with clinically significant coagulopathy
2) Infection at the injection site
3) Allergy to local anesthetics
4) Refusal to technique
5) Patients taking psychotropic medications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Compare effect of Inj Nalbuphine as an adjuvant to Inj Bupivacaine against Inj Bupivacaine alone in terms of <br/ ><br>1. The onset of sensory and motor blockade. <br/ ><br>2. Duration of sensory and motor blockade. <br/ ><br>3. Duration of analgesia (first request for analgesic)Timepoint: 24 hrs
- Secondary Outcome Measures
Name Time Method To assess the hemodynamic parameters in two groups in terms of <br/ ><br>1. Change in Blood pressure (BP). <br/ ><br>2. Change in Respiratory rate. <br/ ><br>3. Change in Oxygen saturation (SpO2).Timepoint: 24 hrs